API landscape in 2022: Drivers and solutions for small molecules
Pharmaceutical Technology
SEPTEMBER 15, 2022
Currently, the data shows that China has the largest number of small molecule API manufacturing facilities, followed by India and the US, with most APIs in US-marketed drugs coming from China and India. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs.
130 
Let's personalize your content